Cargando…

Evaluation of Serum Des-Gamma-Carboxy Prothrombin for the Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma: A Meta-Analysis

AIM: To explore the diagnostic efficacy of des-gamma-carboxy prothrombin (DCP) in hepatitis B virus- (HBV-) related hepatocellular carcinoma (HCC). METHODS: A retrospective study of 459 cases from June 2016 to March 2018 was undertaken, and records of the DCP levels were extracted. The sensitivity,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiu, Wu, Guolin, Li, Youdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193331/ https://www.ncbi.nlm.nih.gov/pubmed/30402170 http://dx.doi.org/10.1155/2018/8906023

Ejemplares similares

A Systematic Review of Des-γ-Carboxy Prothrombin for the Diagnosis of Primary Hepatocellular Carcinoma
por: De, Ji, et al.
Publicado: (2016)

Diagnostic Performance of Des-γ-carboxy Prothrombin for Hepatocellular Carcinoma: A Meta-Analysis
por: Zhu, Rong, et al.
Publicado: (2014)

Prediction of vascular invasion in hepatocellular carcinoma by next-generation des-r-carboxy prothrombin
por: Kurokawa, Tomoharu, et al.
Publicado: (2016)

Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study
por: Ji, Jun, et al.
Publicado: (2016)

The Characteristics and Prognosis of Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin Double-Negative Hepatocellular Carcinoma at Baseline in Higher BCLC Stages
por: Nagahara, Takakazu, et al.
Publicado: (2023)

Next-generation des-r-carboxy prothrombin for immunohistochemical assessment of vascular invasion by hepatocellular carcinoma
por: Yamazaki, Shintaro, et al.
Publicado: (2020)

Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
por: Núñez, Kelley G., et al.
Publicado: (2021)

Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis
por: Yang, Ming, et al.
Publicado: (2019)

Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
por: Lee, Yong Kang, et al.
Publicado: (2013)

Rapid Regression of Advanced Hepatocellular Carcinoma Associated with Elevation of Des-Gamma-Carboxy Prothrombin after Short-Term Treatment with Sorafenib – A Report of Two Cases
por: Nakazawa, Takahide, et al.
Publicado: (2010)

Alteration of non-protein respiratory quotient after hepatocellular carcinoma treatment can be related to des-γ-carboxy prothrombin before treatment
por: Saito, Masaya, et al.
Publicado: (2012)

Artificial neural network models for early diagnosis of hepatocellular carcinoma using serum levels of α-fetoprotein, α-fetoprotein-L3, des-γ-carboxy prothrombin, and Golgi protein 73
por: Li, Bo, et al.
Publicado: (2017)

Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways
por: Cui, Shu-Xiang, et al.
Publicado: (2016)

Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation
por: Yao, Chih-Chien, et al.
Publicado: (2023)

A Novel LC‐MS/MS Assay for Quantification of Des‐carboxy Prothrombin and Characterization of Warfarin‐Induced Changes
por: Basit, Abdul, et al.
Publicado: (2020)

Using Multilevel Structural Equation Modeling (MSEM) to Identify the Predictors and Influencing Mechanism of Technology Use Among Chinese Physicians: An Example from Des-Gamma-Carboxy Prothrombin (DCP)
por: Deng, Qingwen, et al.
Publicado: (2022)

New Thresholds for AFP and Des-γ-Carboxy Prothrombin in Chronic Liver Disease Depending on the Use of Nucleoside Analogs and an Integrated Nomogram
por: Sun, Ting, et al.
Publicado: (2021)

Des-gamma-carboxyprothrombin is a favorable biomarker for the early diagnosis of alfa-fetoprotein-negative hepatitis B virus-related hepatocellular carcinoma
por: Liu, Zhaobo, et al.
Publicado: (2020)

Utility of serum des-gamma-carboxyprothrombin in the diagnosis of hepatocellular carcinoma among Nigerians, a case–control study
por: Ette, Akpakip I., et al.
Publicado: (2015)

Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
por: Yang, Yang, et al.
Publicado: (2021)

Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma
por: Song, Ting, et al.
Publicado: (2019)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study
por: Chen, Huaping, et al.
Publicado: (2017)

Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma
por: Fu, Jun, et al.
Publicado: (2018)

Identification of Key Regulators of Hepatitis C Virus-Induced Hepatocellular Carcinoma by Integrating Whole-Genome and Transcriptome Sequencing Data
por: Chen, Guolin, et al.
Publicado: (2021)

Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients
por: Motawi, Tarek K., et al.
Publicado: (2015)

The contribution of serum hepatitis B virus load in the carcinogenesis and prognosis of hepatocellular carcinoma: evidence from two meta-analyses
por: Chen, Xueqin, et al.
Publicado: (2016)

Structural Organization of Pregenomic RNA and the Carboxy-Terminal Domain of the Capsid Protein of Hepatitis B Virus
por: Wang, Joseph C.-Y., et al.
Publicado: (2012)

Hepatitis Viruses and Human Hepatocellular Carcinoma
por: Kew, Michael C.
Publicado: (1997)

Hepatitis C virus to hepatocellular carcinoma
por: Jahan, Shah, et al.
Publicado: (2012)

Hepatitis C Virus and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2013)

Hepatitis D Virus and Hepatocellular Carcinoma
por: Farci, Patrizia, et al.
Publicado: (2021)

Tumour-associated isoenzymes of gamma-glutamyl transferase in the serum of patients with hepatocellular carcinoma.
por: Kew, M. C., et al.
Publicado: (1984)

Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C
por: Malov, S.I., et al.
Publicado: (2021)

A retrospective discussion of the prognostic value of combining prothrombin time(PT) and fibrinogen(Fbg) in patients with Hepatocellular carcinoma
por: Wang, Xue-Ping, et al.
Publicado: (2017)

Novel Prognostic Scores Based on Plasma Prothrombin Time and Fibrinogen Levels in Patients With AFP-Negative Hepatocellular Carcinoma
por: Mao, Minjie, et al.
Publicado: (2020)

Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients
por: Pan, Yang-Xun, et al.
Publicado: (2021)

Early serum screening for hepatocellular-carcinoma in patients with hepatitis
por: Neguț, Alina Cristina, et al.
Publicado: (2014)

Effect of acupuncture inclusion in the enhanced recovery after surgery protocol on tumor patient gastrointestinal function: a systematic review and meta-analysis of randomized controlled studies
por: Chen, Jiu, et al.
Publicado: (2023)

Hepatitis C virus NS4B carboxy terminal domain is a membrane binding domain
por: Liefhebber, Jolanda MP, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nq4m2b223qk58fbl8dk0e1r13t